193 related articles for article (PubMed ID: 8495195)
1. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
Aulak KS; Davis AE; Donaldson VH; Harrison RA
Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
3. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
[TBL] [Abstract][Full Text] [Related]
5. Two reactive site locations and structure-function study of the arrowhead proteinase inhibitors, A and B, using mutagenesis.
Xie ZW; Luo MJ; Xu WF; Chi CW
Biochemistry; 1997 May; 36(19):5846-52. PubMed ID: 9153425
[TBL] [Abstract][Full Text] [Related]
6. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
7. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
8. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
[TBL] [Abstract][Full Text] [Related]
9. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
[TBL] [Abstract][Full Text] [Related]
10. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor.
Mandle R; Baron C; Roux E; Sundel R; Gelfand J; Aulak K; Davis AE; Rosen FS; Bing DH
J Immunol; 1994 May; 152(9):4680-5. PubMed ID: 7512602
[TBL] [Abstract][Full Text] [Related]
11. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.
Verpy E; Couture-Tosi E; Eldering E; Lopez-Trascasa M; Späth P; Meo T; Tosi M
J Clin Invest; 1995 Jan; 95(1):350-9. PubMed ID: 7814636
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant C1 inhibitor P1 variants.
Eldering E; Huijbregts CC; Lubbers YT; Longstaff C; Hack CE
J Biol Chem; 1992 Apr; 267(10):7013-20. PubMed ID: 1551909
[TBL] [Abstract][Full Text] [Related]
13. [Amino acid sequence in the reactive site region of an acid-stable inhibitor of trypsin, chymotrypsin and intracellular proteinases from rabbit serum].
Ogloblina OG; Varchenko NV; Paskhina TS; Khodova OM; Baratova LA
Bioorg Khim; 1983 Feb; 9(2):193-9. PubMed ID: 6679768
[TBL] [Abstract][Full Text] [Related]
14. The assignment of the reactive sites of the double-headed arrowhead proteinase inhibitor A and B.
Li J; Ruan KC; Chi CW
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):662-6. PubMed ID: 12198573
[TBL] [Abstract][Full Text] [Related]
15. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
Lovato DV; Nicolau de Campos IT; Amino R; Tanaka AS
Biochimie; 2006 Jun; 88(6):673-81. PubMed ID: 16469426
[TBL] [Abstract][Full Text] [Related]
16. Replacement of lysine by arginine, phenylalanine and tryptophan in the reactive site of the bovine trypsin-kallikrein inhibitor (Kunitz) and change of the inhibitory properties.
Jering H; Tschesche H
Eur J Biochem; 1976 Jan; 61(2):453-63. PubMed ID: 129327
[TBL] [Abstract][Full Text] [Related]
17. Bovine factor XIIa inhibitor.
Muldbjerg M; Markussen S; Magnusson S; Halkier T
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):47-54. PubMed ID: 8457651
[TBL] [Abstract][Full Text] [Related]
18. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
19. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
Davis AE; Aulak K; Parad RB; Stecklein HP; Eldering E; Hack CE; Kramer J; Strunk RC; Bissler J; Rosen FS
Nat Genet; 1992 Aug; 1(5):354-8. PubMed ID: 1363816
[TBL] [Abstract][Full Text] [Related]
20. Primary structure and reactive site of a novel wheat proteinase inhibitor of subtilisin and chymotrypsin.
Poerio E; Di Gennaro S; Di Maro A; Farisei F; Ferranti P; Parente A
Biol Chem; 2003 Feb; 384(2):295-304. PubMed ID: 12675523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
